or Try an Advanced Search...

    Technical Analysis for CPH - Cipher Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    B 8.680 -1.48% -0.130
    CPH closed down 1.48 percent on Friday, July 26, 2024, on approximately normal volume. It was able to find support at its 50 day moving average.
    Earnings due: Aug 8
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Flat
    Historical CPH trend table...
    Date Alert Name Type % Chg
    50 DMA Support Bullish 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Calm After Storm Range Contraction -1.48%
    Upper Bollinger Band Walk Strength -1.48%
    Upper Bollinger Band Touch Strength -1.48%
    Gapped Down Weakness -1.48%
    180 Bullish Setup Bullish Swing Setup -2.69%
    Pocket Pivot Bullish Swing Setup -2.69%
    Upper Bollinger Band Walk Strength -2.69%
    Upper Bollinger Band Touch Strength -2.69%
    Older End-of-Day Signals for CPH ...

       Recent Intraday Alerts

    Alert Time
    Down 2% about 7 hours ago
    Fell Below 50 DMA about 7 hours ago
    Fell Below 10 DMA about 7 hours ago
    10 DMA Support about 8 hours ago
    Fell Below Previous Day's Low about 11 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CPH Chart by TradingView
    Basic chart:

    Profile

    Cipher Pharmaceuticals Inc. Description

    Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.

    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Pipe Pharma Pharmaceutical Pipeline RTT Skin Pharmaceuticals IPO Organ Systems Arthritis Ulcer Dermatology Nail Psoriasis Acne Actinic Keratosis Herpes Labialis Keratosis Onychomycosis Rheumatoid Arthritis

    Is CPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 14 Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders
    May 13 Cipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50
    May 11 Cipher Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
    May 9 Cipher Pharmaceuticals Reports First Quarter 2024 Results
    May 3 Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call
    Apr 26 Cipher Pharmaceuticals Inc.'s (TSE:CPH) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
    Apr 3 Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
    Mar 16 Cipher Pharmaceuticals' (TSE:CPH) three-year earnings growth trails the 93% YoY shareholder returns
    Mar 14 Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results
    Mar 8 Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
    See more CPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.33
    52 Week Low 3.35
    Average Volume 18,415
    200-Day Moving Average 7.208
    50-Day Moving Average 8.598
    20-Day Moving Average 8.471
    10-Day Moving Average 8.644
    Average True Range 0.277
    RSI (14) 53.70
    ADX 20.13
    +DI 25.593
    -DI 21.422
    Chandelier Exit (Long, 3 ATRs) 8.440
    Chandelier Exit (Short, 3 ATRs) 8.840
    Upper Bollinger Bands 8.998
    Lower Bollinger Band 7.944
    Percent B (%b) 0.7
    BandWidth 12.445
    MACD Line 0.079
    MACD Signal Line 0.021
    MACD Histogram 0.0575
    Fundamentals Value
    Market Cap 234.61 Million
    Num Shares 27 Million
    EPS 0.28
    Price-to-Earnings (P/E) Ratio 30.67
    Price-to-Sales 0.85
    Price-to-Book 0.55
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.190
    Resistance 3 (R3) 9.203 9.047 9.105
    Resistance 2 (R2) 9.047 8.917 9.040 9.077
    Resistance 1 (R1) 8.863 8.837 8.785 8.850 9.048
    Pivot Point 8.707 8.707 8.668 8.700 8.707
    Support 1 (S1) 8.523 8.577 8.445 8.510 8.312
    Support 2 (S2) 8.367 8.497 8.360 8.283
    Support 3 (S3) 8.183 8.367 8.255
    Support 4 (S4) 8.170